Research Conducted by Deflux™ Confirms 43% of Women Keep Health Problems a Secret
New research conducted by Deflux™ has shown that nearly half of women surveyed have kept secrets from their partners including a worry or concern about a health issue.
In the research, conducted by Deflux™ (http://www.deflux.com/
The results further indicated that out of the 100 women asked in the UK, 43% were keeping a more serious health issue quiet. Deflux™ understands this all too well. As a treatment for bladder weakness, specifically Stress Urinary Incontinence (SUI) (http://www.defluxsui.com/)
And GPs agree – Dr. Ellie Canon told us “Bladder weakness is one of the last taboo topics. Women seem to be able to talk about more-or-less anything else – STIs, periods, the gory details of labour and yet I have to really probe in order to get a woman to tell me about her bladder weakness. It’s such a common condition, but because people seem to associate the word “incontinence”
It’s a difficult thing to come to terms with, let alone be in control of, so for many it’s been kept a personal matter not to be discussed; a secret hidden from others.However, Steve Foley, Consultant Urologist at the Royal Berkshire Hospital in Reading believes bladder weakness is a much more widespread problem than the statistics suggest. He says, “My belief is that the majority of women will suffer from this condition, either because of childbirth or the menopause. It is a silent epidemic that women are really scared to talk about, but injection therapy (http://www.deflux.com/
Deflux™: is a simple and effective treatment for SUI.Deflux™ available both privately and on the NHS, is a gel used during injection therapy. During the procedure, the gel is injected into the urethra endoscopically to obtain a bulking effect, which helps to prevent urine leakage. The procedure which is safe, quick and effective and can be administered under general anaesthetic or local sedation, which means potentially there’s no need for an overnight stay in hospital. Patients generally can return to normal activity within 24-48 hours.
SUI is the most common form of incontinence and occurs when there is extra pressure on the bladder, causing a leakage of urine. In clinical trials the Deflux™ procedure had a 74% success rate in the mild to moderate incontinent group and the treatment itself lasts for up to 5 years. As the research suggests, some women may not want to admit that they’re sufferers of SUI themselves but in this case, it might be one secret that’sworth sharing.
About Deflux™: Deflux™ gel is a viscous substance consisting of two components: dextranomer (Dx) microspheres and stabilised hyaluronic acid of non-animal origin (NASHA™). Deflux™ is completely safe and has been successfully used for a decade to treatment more than 200,000 children affected with vesicoureteral reflux. In the treatment of SUI, the dextranomer beads act as the bulking agent and have been shown to remain at the injection site for up to four years. The hyaluronic acid is the carrier agent, which disappears from the body.
For more information, images, videos or interviews with Steve Foley, please contact Cream Communications on 0845 388 9584/07715709982 or email email@example.comfirstname.lastname@example.org
Notes to Editors
· The procedure is available both on the NHS and privately.
· Read more about Steve Foley at www.expertsources.co.uk